Defense lawyers and insurance adjusters often point to a positive marijuana lab result as if it proves a driver was impaired at the moment of a crash. That overstates what the test shows. THC metabolite testing measures chemical byproducts left after the body processes tetrahydrocannabinol, the main psychoactive compound in cannabis. The most common target is 11-nor-9-carboxy-THC (THC-COOH), an inactive metabolite found in urine or blood after use. A positive result can mean prior exposure, not current impairment, because metabolites may remain detectable for days or weeks after the intoxicating effects have ended.

That distinction matters in real cases. Active THC in blood may support an argument about recent use, but metabolite-only testing is weaker evidence of diminished driving ability, slowed reaction time, or poor judgment. In a crash involving black ice on the Pell Bridge or a pothole from spring frost heaves in Providence County, a metabolite result does not by itself prove the cannabis user caused the wreck. Lawyers often challenge causation, toxicology, chain of custody, and the timing of sample collection.

For an injury claim, a positive metabolite test can still affect negotiations by giving the insurer a basis to argue comparative negligence. Rhode Island does not use a fixed per se nanogram threshold for marijuana impairment like the 0.08% alcohol rule; the dispute usually turns on the total evidence. Even then, Rhode Island's minimum auto liability coverage remains 25/50/25 under state insurance requirements, which can limit recovery regardless of the toxicology dispute.